Establishment and characterization of esophageal squamous cell carcinoma patient-derived xenograft mouse models for preclinical drug discovery

Development and characterization of a bladder cancer xenograft model using patient-derived tumor tissue

(2013) Bumsoo Park et al.   CANCER SCIENCE

Esophageal carcinoma

(2013) Patrick M. Boland et al.   CURRENT OPINION IN ONCOLOGY

Frequency, characterization, and prognostic analysis of PIK3CA gene mutations in Chinese esophageal squamous cell carcinoma

(2013) Jun Hou et al.   HUMAN PATHOLOGY

Primary esophageal and gastro-esophageal junction cancer xenograft models: clinicopathological features and engraftment

(2013) Lorin Dodbiba et al.   LABORATORY INVESTIGATION

Oesophageal carcinoma

(2013) Arjun Pennathur et al.   LANCET

Chemoradiotherapy with or without cetuximab in patients with oesophageal cancer (SCOPE1): a multicentre, phase 2/3 randomised trial

(2013) Thomas Crosby et al.   LANCET ONCOLOGY

Preoperative Cetuximab, Irinotecan, Cisplatin, and Radiation Therapy for Patients With Locally Advanced Esophageal Cancer

(2013) M. S. Lee et al.   ONCOLOGIST

Trastuzumab anti-tumor efficacy in patient-derived esophageal squamous cell carcinoma xenograft (PDECX) mouse models

(2012) Xianhua Wu et al.   Journal of Translational Medicine

Patient-derived tumour xenografts as models for oncology drug development

(2012) John J. Tentler et al.   Nature Reviews Clinical Oncology

Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer

(2012) P. van Hagen et al.   NEW ENGLAND JOURNAL OF MEDICINE

Neoadjuvant Paclitaxel Poliglumex, Cisplatin, and Radiation for Esophageal Cancer

(2011) Thomas Dipetrillo et al.   AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS

Trastuzumab has anti-metastatic and anti-angiogenic activity in a spontaneous metastasis xenograft model of esophageal adenocarcinoma

(2011) Tobias Lange et al.   CANCER LETTERS

Multidisciplinary Management of Early and Locally Advanced Esophageal Cancer

(2011) Jussuf T. Kaifi et al.   JOURNAL OF CLINICAL GASTROENTEROLOGY

Cetuximab in Combination With Chemoradiotherapy Before Surgery in Patients With Resectable, Locally Advanced Esophageal Carcinoma: A Prospective, Multicenter Phase IB/II Trial (SAKK 75/06)

(2011) Thomas Ruhstaller et al.   JOURNAL OF CLINICAL ONCOLOGY

Inhibition of Oesophageal Squamous Cell Carcinoma Progression by in vivo Targeting of Hyaluronan Synthesis

(2011) Sören Twarock et al.   Molecular Cancer

Phase II Study of Docetaxel and Cisplatin Chemotherapy in 5-Fluorouracil/Cisplatin Pretreated Esophageal Cancer

(2010) Hyun-Jeong Shim et al.   AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS

Cancer incidence in British Indians and British whites in Leicester, 2001–2006

(2010) R Ali et al.   BRITISH JOURNAL OF CANCER

The establishment of a new mouse model with orthotopic esophageal cancer showing the esophageal stricture

(2010) Toshiaki Ohara et al.   CANCER LETTERS

Patient-derived human tumour tissue xenografts in immunodeficient mice: a systematic review

(2010) Ketao Jin et al.   Clinical & Translational Oncology

Cetuximab as Second-Line Therapy in Patients with Metastatic Esophageal Adenocarcinoma: A Phase II Southwest Oncology Group Study (S0415)

(2010) Philip J. Gold et al.   Journal of Thoracic Oncology

Phase II Study of Preoperative Pemetrexed, Carboplatin, and Radiation Followed by Surgery for Locally Advanced Esophageal Cancer and Gastroesophageal Junction Tumors

(2010) Aminah Jatoi et al.   Journal of Thoracic Oncology

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial

(2010) Yung-Jue Bang et al.   LANCET

Effective Therapeutic Targeting of the Overexpressed HER-2 Receptor in a Highly Metastatic Orthotopic Model of Esophageal Carcinoma

(2010) S. J. Gros et al.   MOLECULAR CANCER THERAPEUTICS

Multicenter phase II trial of preoperative induction chemotherapy followed by chemoradiation with docetaxel and cisplatin for locally advanced esophageal carcinoma (SAKK 75/02)

(2009) T. Ruhstaller et al.   ANNALS OF ONCOLOGY

Evaluation of gene amplification and protein expression of HER-2/neu in esophageal squamous cell carcinoma using Fluorescence in situ Hybridization (FISH) and immunohistochemistry

(2009) Yukie Sato-Kuwabara et al.   BMC CANCER

A Primary Xenograft Model of Small-Cell Lung Cancer Reveals Irreversible Changes in Gene Expression Imposed by Culture In vitro

(2009) V. C. Daniel et al.   CANCER RESEARCH

Sorafenib induces growth suppression in mouse models of gastrointestinal stromal tumor

(2009) H. Huynh et al.   MOLECULAR CANCER THERAPEUTICS

Recent trends of HER-2 testing and trastuzumab therapy for breast cancer

(2009) Masafumi Kurosumi   Breast Cancer

HER2 in gastric cancer: a new prognostic factor and a novel therapeutic target

(2008) C. Gravalos et al.   ANNALS OF ONCOLOGY

Establishment of Patient-Derived Non-Small Cell Lung Cancer Xenografts as Models for the Identification of Predictive Biomarkers

(2008) I. Fichtner et al.   CLINICAL CANCER RESEARCH

Assessment of a HER2 scoring system for gastric cancer: results from a validation study

(2008) M Hofmann et al.   HISTOPATHOLOGY

From Human to Mouse and Back: 'Tumorgraft' Models Surge in Popularity

(2008) K. Garber   JNCI-Journal of the National Cancer Institute